undamentalytics Newsletter
Sign in

Labcorp cash flow statement

In fiscal 2025, Labcorp's operations generated $1.64bn of cash; it spent $435m on capital projects, leaving free cash flow of $1.21bn. It returned $241m in dividends and $450m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash from operations8628848568418197399821,1971,4981,3051,4452,1353,1101,9561,3281,5861,6411,815
Depreciation and amortisation195204231230230246458499533552577625577537577644681708
Stock-based pay36404941374610211011092107112133117129117126127
Capital spending115126146174202204256279313380400382422429454490435528
Free cash flow7487587106686175367279181,1859261,0451,7542,6881,5278741,0961,2061,287
Free cash flow after stock pay7117186616275794906258091,0768349381,6422,5551,4107459791,0801,160
Dividends paid———————————00195254243241237
Share buybacks2733386445171,0162690443387004501001,6691,1001,000250450677

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: DVA vs LHBTSG vs LHDGX vs LH

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Labcorp's SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Labcorp.